We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+22.28%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$12.5M
Cap. Flow
+$1.13M
Cap. Flow %
0.9%
Top 10 Hldgs %
46.68%
Holding
92
New
9
Increased
16
Reduced
49
Closed
1

Top Buys

Rank Stock Value
1
OWLT icon
Owlet
OWLT
+$1.16M
2
NEOG icon
Neogen
NEOG
+$1.13M
3
VERI icon
Veritone
VERI
+$944K
4
PROF
Profound Medical
PROF
+$734K
5
CPSH icon
CPS Technologies
CPSH
+$715K

Top Sells

Rank Stock Value
1
BKSY icon
BlackSky Technology
BKSY
+$1.83M
2
SKYT
SkyWater Technology
SKYT
+$632K
3
CIEN icon
Ciena
CIEN
+$601K
4
HAIN icon
Hain Celestial
HAIN
+$335K
5
OPRX icon
OptimizeRx
OPRX
+$330K

Sector Composition

Rank Sector Weight
1 Healthcare 64.31%
2 Technology 24.24%
3 Communication Services 5.8%
4 Industrials 2.52%
5 Consumer Staples 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INUV icon
26
Inuvo
INUV
$18M
$1.45M 1.15%
585,291
-85,681
-13% -$247K
ABBV icon
27
AbbVie
ABBV
$431B
$1.33M 1.06%
5,842
– –
PERI icon
28
Perion Network
PERI
$386M
$1.33M 1.05%
138,375
+15,425
+13% +$150K
BLZE icon
29
Backblaze
BLZE
$1.19B
$1.3M 1.03%
278,775
-1,250
-0.4% -$8.57K
AAPL icon
30
Apple
AAPL
$4.52T
$1.26M 1%
4,650
– –
CXDO icon
31
Crexendo
CXDO
$242M
$1.26M 1%
194,850
+26,000
+15% +$170K
NEOG icon
32
Neogen
NEOG
$2.58B
$1.25M 0.99%
+179,250
New +$1.13M
LUCD icon
33
Lucid Diagnostics
LUCD
$183M
$1.23M 0.97%
1,126,000
-1,000
-0.1% -$1.12K
VELO
34
Velo3D Inc
VELO
$408M
$1.2M 0.95%
87,000
+17,000
+24% +$117K
ZETA icon
35
Zeta Global
ZETA
$6.05B
$1.15M 0.91%
56,500
-1,000
-2% -$18.7K
NMTC icon
36
NeuroOne Medical Technologies
NMTC
$14.7M
$1.12M 0.89%
245,500
+833
+0.3% +$3.79K
CSTL icon
37
Castle Biosciences
CSTL
$953M
$1.09M 0.87%
28,045
-100
-0.4% -$3.22K
ATRC icon
38
AtriCure
ATRC
$1.98B
$1.09M 0.86%
27,450
-300
-1% -$11K
GILD icon
39
Gilead Sciences
GILD
$168B
$1.01M 0.81%
8,266
– –
USIO icon
40
Usio Inc
USIO
$62.1M
$960K 0.76%
705,932
-152,261
-18% -$216K
PFE icon
41
Pfizer
PFE
$145B
$929K 0.74%
37,309
-1,700
-4% -$42.9K
MRK icon
42
Merck
MRK
$316B
$921K 0.73%
8,750
– –
PROF
43
Profound Medical
PROF
$304M
$899K 0.71%
+114,280
New +$734K
CDXS icon
44
Codexis
CDXS
$154M
$863K 0.69%
529,500
+221,800
+72% +$452K
VERI icon
45
Veritone
VERI
$112M
$817K 0.65%
+175,600
New +$944K
DAWN
46
DELISTED
Day One Biopharmaceuticals
DAWN
$783K 0.62%
84,000
+1,750
+2% +$14.6K
VTRS icon
47
Viatris
VTRS
$20.6B
$721K 0.57%
57,895
+200
+0.3% +$2.16K
USB icon
48
US Bancorp
USB
$100B
$670K 0.53%
12,550
-350
-3% -$17.2K
ANIP icon
49
ANI Pharmaceuticals
ANIP
$1.8B
$666K 0.53%
8,441
– –
CELC icon
50
Celcuity
CELC
$4.51B
$638K 0.51%
6,400
-1,500
-19% -$123K
1
2
3 4

Similar funds

PWP
Phillips Wealth Planners Starkville, Mississippi $133M AUM 20.41% 1-Year Est. Return
BF
Bonfire Financial Colorado Springs, Colorado $133M AUM 12.09% 1-Year Est. Return
SFG
Synergy Financial Group San Ramon, California $133M AUM 22.16% 1-Year Est. Return
HWMG
Harbour Wealth Management Group Daniel Island, South Carolina $133M AUM
FTEA
Forty-three Eighteen Advisors Bentonville, Arkansas $133M AUM
WT
WHI Trust Chicago, Illinois $133M AUM
BAM
Brickwood Asset Management London, United Kingdom $133M AUM 10.27% 1-Year Est. Return
WLG
Williamson Legacy Group Carmel, Indiana $133M AUM 151.36% 1-Year Est. Return

Perkins Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Perkins Capital Management held 92 positions worth $126M, up 11% from $113M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Perkins Capital Management's Q4 2025 filing shows 9 new, 16 increased, 49 reduced and 1 closed positions. Its largest new stake was Owlet: 102,105 shares worth $1.65M. The largest sale was BlackSky Technology, an estimated $1.83M.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 58% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q4 2025 buy was Owlet: 102,105 shares worth $1.65M.
  • Perkins Capital Management added most to TELA Bio in Q4 2025, an estimated $713K increase.
  • Perkins Capital Management's biggest Q4 2025 reduction was BlackSky Technology, cutting an estimated $1.83M.
  • Perkins Capital Management fully exited Quest Diagnostics in Q4 2025, selling an estimated $229K.
  • Perkins Capital Management's ten largest holdings make up 47% of its $126M portfolio in Q4 2025.
  • Perkins Capital Management opened 9 new positions and closed 1 in Q4 2025.
  • Perkins Capital Management's portfolio value rose 11% quarter-over-quarter to $126M.

Based on Perkins Capital Management's 13F filing for Q4 2025, filed 4 Feb 2026.